|
TPST1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.17609996478308E-09 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.109410E-01 |
| Stage1-vs-Stage3 |
4.333800E-01 |
| Stage1-vs-Stage4 |
8.197100E-03 |
| Stage2-vs-Stage3 |
7.163800E-02 |
| Stage2-vs-Stage4 |
3.480200E-03 |
| Stage3-vs-Stage4 |
1.105400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.87690000044805E-07 |
| Normal-vs-Asian |
1.6295853555448E-12 |
| Caucasian-vs-AfricanAmerican |
2.967800E-01 |
| Caucasian-vs-Asian |
4.334000E-01 |
| AfricanAmerican-vs-Asian |
1.847190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.950800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64412927716739E-12 |
| Normal-vs-Age(81-100Yrs) |
2.033600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.814400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.719800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.847800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.526400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.555800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.531800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.206820E-04 |
| Classical-VS-Follicular |
1.086480E-02 |
| Classical-VS-Other |
4.275400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
3.54820000048051E-07 |
| Tall-VS-Other |
3.658800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.179770E-01 |
| Follicular-VS-Normal |
5.53710410855501E-11 |
| Other-VS-Normal |
1.26710000003527E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
4.9575999971907E-09 |
|
|
